{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:54Z","timestamp":1791275814933,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,3,21]],"date-time":"2013-03-21T00:00:00Z","timestamp":1363824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10552-013-0186-0","type":"journal-article","created":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T01:29:32Z","timestamp":1363742972000},"page":"1087-1097","source":"Crossref","is-referenced-by-count":11,"title":["Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women"],"prefix":"10.1007","volume":"24","author":[{"given":"Scott R.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e T.","family":"Fortner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Heather Eliassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Hankinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley S.","family":"Tworoger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,21]]},"reference":[{"issue":"9","key":"186_CR1","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1054\/bjoc.2000.1709","volume":"84","author":"SA Khuder","year":"2001","unstructured":"Khuder SA, Mutgi AB (2001) Breast cancer and NSAID use: a meta-analysis. Br J Cancer 84(9):1188\u20131192","journal-title":"Br J Cancer"},{"issue":"7","key":"186_CR2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10552-006-0033-7","volume":"17","author":"C Bosetti","year":"2006","unstructured":"Bosetti C, Gallus S, La Vecchia C (2006) Aspirin and cancer risk: an updated quantitative review to 2005. Cancer Causes Control 17(7):871\u2013888","journal-title":"Cancer Causes Control"},{"key":"186_CR3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-3-28","volume":"3","author":"A Gonzalez-Perez","year":"2003","unstructured":"Gonzalez-Perez A, Garcia Rodriguez LA, Lopez-Ridaura R (2003) Effects of non-steroidal anti-inflammatory drugs on cancer sites other than the colon and rectum: a meta-analysis. BMC Cancer 3:28","journal-title":"BMC Cancer"},{"issue":"2","key":"186_CR4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1503","volume":"17","author":"S Mangiapane","year":"2008","unstructured":"Mangiapane S, Blettner M, Schlattmann P (2008) Aspirin use and breast cancer risk: a meta-analysis and meta-regression of observational studies from 2001 to 2005. Pharmacoepidemiol Drug Saf 17(2):115\u2013124","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"186_CR5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1158\/1055-9965.EPI-07-2828","volume":"17","author":"KB Moysich","year":"2008","unstructured":"Moysich KB, Beehler GP, Zirpoli G, Choi JY, Baker JA (2008) Use of common medications and breast cancer risk. Cancer Epidemiol Biomarkers Prev 17(7):1564\u20131595","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"20","key":"186_CR6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/jnci\/djn324","volume":"100","author":"B Takkouche","year":"2008","unstructured":"Takkouche B, Regueira-Mendez C, Etminan M (2008) Breast cancer and use of nonsteroidal anti-inflammatory drugs: a meta-analysis. J Natl Cancer Inst 100(20):1439\u20131447","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"186_CR7","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10549-008-0228-6","volume":"117","author":"YS Zhao","year":"2009","unstructured":"Zhao YS, Zhu S, Li XW, Wang F, Hu FL, Li DD, Zhang WC, Li X (2009) Association between NSAIDs use and breast cancer risk: a systematic review and meta-analysis. Breast Cancer Res Treat 117(1):141\u2013150","journal-title":"Breast Cancer Res Treat"},{"key":"186_CR8","doi-asserted-by":"crossref","unstructured":"Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE (2009) Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses\u2019 Health Study II. Arch Intern Med 169(2):115\u2013121; discussion 121","DOI":"10.1001\/archinternmed.2008.537"},{"issue":"2","key":"186_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/aje\/kwm278","volume":"167","author":"SS Tworoger","year":"2008","unstructured":"Tworoger SS, Lee IM, Buring JE, Hankinson SE (2008) Plasma androgen concentrations and risk of incident ovarian cancer. Am J Epidemiol 167(2):211\u2013218","journal-title":"Am J Epidemiol"},{"issue":"11","key":"186_CR10","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/aje\/kwp062","volume":"169","author":"SP Pinheiro","year":"2009","unstructured":"Pinheiro SP, Tworoger SS, Cramer DW, Rosner BA, Hankinson SE (2009) Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts. Am J Epidemiol 169(11):1378\u20131387","journal-title":"Am J Epidemiol"},{"issue":"2","key":"186_CR11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2125.2005.02386.x","volume":"60","author":"S Bonovas","year":"2005","unstructured":"Bonovas S, Filioussi K, Sitaras NM (2005) Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis. Br J Clin Pharmacol 60(2):194\u2013203","journal-title":"A meta-analysis. Br J Clin Pharmacol"},{"issue":"1","key":"186_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2125.2005.02526.x","volume":"62","author":"S Bonovas","year":"2006","unstructured":"Bonovas S, Filioussi K, Sitaras NM (2006) Paracetamol use and risk of ovarian cancer: a meta-analysis. Br J Clin Pharmacol 62(1):113\u2013121","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"186_CR13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1023\/A:1016380917625","volume":"13","author":"KM Fairfield","year":"2002","unstructured":"Fairfield KM, Hunter DJ, Fuchs CS, Colditz GA, Hankinson SE (2002) Aspirin, other NSAIDs, and ovarian cancer risk (United States). Cancer Causes Control 13(6):535\u2013542","journal-title":"Cancer Causes Control"},{"issue":"12","key":"186_CR14","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1093\/aje\/kwn082","volume":"167","author":"CG Hannibal","year":"2008","unstructured":"Hannibal CG, Rossing MA, Wicklund KG, Cushing-Haugen KL (2008) Analgesic drug use and risk of epithelial ovarian cancer. Am J Epidemiol 167(12):1430\u20131437","journal-title":"Am J Epidemiol"},{"issue":"2","key":"186_CR15","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ijc.11538","volume":"108","author":"JV Lacey Jr","year":"2004","unstructured":"Lacey JV Jr, Sherman ME, Hartge P, Schatzkin A, Schairer C (2004) Medication use and risk of ovarian carcinoma: a prospective study. Int J Cancer 108(2):281\u2013286","journal-title":"Int J Cancer"},{"issue":"9","key":"186_CR16","first-page":"933","volume":"9","author":"L Rosenberg","year":"2000","unstructured":"Rosenberg L, Palmer JR, Rao RS, Coogan PF, Strom BL, Zauber AG, Stolley PD, Shapiro S (2000) A case-control study of analgesic use and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9(9):933\u2013937","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"186_CR17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1097\/01.ede.0000190538.55645.f8","volume":"17","author":"JM Schildkraut","year":"2006","unstructured":"Schildkraut JM, Moorman PG, Halabi S, Calingaert B, Marks JR, Berchuck A (2006) Analgesic drug use and risk of ovarian cancer. Epidemiology 17(1):104\u2013107","journal-title":"Epidemiology"},{"issue":"11","key":"186_CR18","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/sj.bjc.6604392","volume":"98","author":"KJ Wernli","year":"2008","unstructured":"Wernli KJ, Newcomb PA, Hampton JM, Trentham-Dietz A, Egan KM (2008) Inverse association of NSAID use and ovarian cancer in relation to oral contraceptive use and parity. Br J Cancer 98(11):1781\u20131783","journal-title":"Br J Cancer"},{"issue":"12","key":"186_CR19","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/1055-9965.EPI-05-0457","volume":"14","author":"KB Moysich","year":"2005","unstructured":"Moysich KB, Baker JA, Rodabaugh KJ, Villella JA (2005) Regular analgesic use and risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 14(12):2923\u20132928","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"186_CR20","doi-asserted-by":"crossref","unstructured":"Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ (2011) Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort. Am J Gastroenterol 106:1340\u20131350","DOI":"10.1038\/ajg.2011.38"},{"issue":"5","key":"186_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","volume":"146","author":"C Dube","year":"2007","unstructured":"Dube C, Rostom A, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146(5):365\u2013375","journal-title":"Ann Intern Med"},{"issue":"5","key":"186_CR22","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","volume":"146","author":"A Rostom","year":"2007","unstructured":"Rostom A, Dube C, Lewin G, Tsertsvadze A, Barrowman N, Code C, Sampson M, Moher D (2007) Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146(5):376\u2013389","journal-title":"Ann Intern Med"},{"issue":"9754","key":"186_CR23","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(10)61543-7","volume":"376","author":"PM Rothwell","year":"2010","unstructured":"Rothwell PM, Wilson M, Elwin CE, Norrving B, Algra A, Warlow CP, Meade TW (2010) Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 376(9754):1741\u20131750","journal-title":"Lancet"},{"issue":"12","key":"186_CR24","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1200\/JCO.2006.07.6356","volume":"25","author":"SS Tworoger","year":"2007","unstructured":"Tworoger SS, Eliassen AH, Sluss P, Hankinson SE (2007) A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. J Clin Oncol 25(12):1482\u20131488","journal-title":"J Clin Oncol"},{"issue":"1","key":"186_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10911-008-9063-y","volume":"13","author":"SS Tworoger","year":"2008","unstructured":"Tworoger SS, Hankinson SE (2008) Prolactin and breast cancer etiology: an epidemiologic perspective. J Mammary Gland Biol Neoplasia 13(1):41\u201353","journal-title":"J Mammary Gland Biol Neoplasia"},{"issue":"4","key":"186_CR26","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-05-3369","volume":"66","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Sluss P, Hankinson SE (2006) Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res 66(4):2476\u20132482","journal-title":"Cancer Res"},{"issue":"2","key":"186_CR27","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/bcr2089","volume":"10","author":"GL Gierach","year":"2008","unstructured":"Gierach GL, Lacey JV Jr, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, Brinton LA (2008) Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health-AARP Diet and Health Study. Breast Cancer Res 10(2):R38","journal-title":"Breast Cancer Res"},{"issue":"11","key":"186_CR28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97(11):805\u2013812","journal-title":"J Natl Cancer Inst"},{"issue":"17","key":"186_CR29","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1093\/jnci\/90.17.1292","volume":"90","author":"SE Hankinson","year":"1998","unstructured":"Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE (1998) Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90(17):1292\u20131299","journal-title":"J Natl Cancer Inst"},{"key":"186_CR30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/978-0-387-78818-0_10","volume":"630","author":"AH Eliassen","year":"2008","unstructured":"Eliassen AH, Hankinson SE (2008) Endogenous hormone levels and risk of breast, endometrial and ovarian cancers: prospective studies. Adv Exp Med Biol 630:148\u2013165","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"186_CR31","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1158\/1055-9965.EPI-09-0975","volume":"19","author":"MA Gates","year":"2010","unstructured":"Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE (2010) Analgesic use and sex steroid hormone concentrations in postmenopausal women. Cancer Epidemiol Biomarkers Prev 19(4):1033\u20131041","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"186_CR32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1055-9965.EPI-07-2739","volume":"17","author":"AG Hudson","year":"2008","unstructured":"Hudson AG, Gierach GL, Modugno F, Simpson J, Wilson JW, Evans RW, Vogel VG, Weissfeld JL (2008) Nonsteroidal anti-inflammatory drug use and serum total estradiol in postmenopausal women. Cancer Epidemiol Biomarkers Prev 17(3):680\u2013687","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"186_CR33","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s10549-007-9588-6","volume":"108","author":"A McTiernan","year":"2008","unstructured":"McTiernan A, Wu L, Barnabei VM, Chen C, Hendrix S, Modugno F, Rohan T, Stanczyk FZ, Wang CY (2008) Relation of demographic factors, menstrual history, reproduction and medication use to sex hormone levels in postmenopausal women. Breast Cancer Res Treat 108(2):217\u2013231","journal-title":"Breast Cancer Res Treat"},{"issue":"17","key":"186_CR34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/87.17.1297","volume":"87","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE, Willett WC, Manson JE, Hunter DJ, Colditz GA, Stampfer MJ, Longcope C, Speizer FE (1995) Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst 87(17):1297\u20131302","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"186_CR35","doi-asserted-by":"crossref","first-page":"R97","DOI":"10.1186\/ar2742","volume":"11","author":"EW Karlson","year":"2009","unstructured":"Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, Fraser PA, Tworoger S, Hankinson SE, Lee IM et al (2009) A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther 11(3):R97","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"186_CR36","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1158\/1055-9965.EPI-05-0848","volume":"15","author":"SA Missmer","year":"2006","unstructured":"Missmer SA, Spiegelman D, Bertone-Johnson ER, Barbieri RL, Pollak MN, Hankinson SE (2006) Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev 15(5):972\u2013978","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"186_CR37","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/jnci\/djh336","volume":"96","author":"SA Missmer","year":"2004","unstructured":"Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE (2004) Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96(24):1856\u20131865","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"186_CR38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0022-4731(82)90038-3","volume":"16","author":"R Sodergard","year":"1982","unstructured":"Sodergard R, Backstrom T, Shanbhag V, Carstensen H (1982) Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16(6):801\u2013810","journal-title":"J Steroid Biochem"},{"key":"186_CR39","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B (1983) Percentage points for a generalized ESD many-outlier procedure. Technometrics 25:165\u2013172","journal-title":"Technometrics"},{"issue":"6","key":"186_CR40","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/aje\/kwm348","volume":"167","author":"B Rosner","year":"2008","unstructured":"Rosner B, Cook N, Portman R, Daniels S, Falkner B (2008) Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol 167(6):653\u2013666","journal-title":"Am J Epidemiol"},{"issue":"1","key":"186_CR41","first-page":"71","volume":"76","author":"VY Fujimoto","year":"1990","unstructured":"Fujimoto VY, Clifton DK, Cohen NL, Soules MR (1990) Variability of serum prolactin and progesterone levels in normal women: the relevance of single hormone measurements in the clinical setting. Obstet Gynecol 76(1):71\u201378","journal-title":"Obstet Gynecol"},{"key":"186_CR42","volume-title":"Applied logistic regression","author":"DW Hosmer","year":"1989","unstructured":"Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York"},{"issue":"3","key":"186_CR43","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2174\/187152006776930873","volume":"6","author":"ES Diaz-Cruz","year":"2006","unstructured":"Diaz-Cruz ES, Brueggemeier RW (2006) Interrelationships between cyclooxygenases and aromatase: unraveling the relevance of cyclooxygenase inhibitors in breast cancer. Anticancer Agents Med Chem 6(3):221\u2013232","journal-title":"Anticancer Agents Med Chem"},{"issue":"12","key":"186_CR44","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.1210\/en.137.12.5739","volume":"137","author":"Y Zhao","year":"1996","unstructured":"Zhao Y, Agarwal VR, Mendelson CR, Simpson ER (1996) Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 137(12):5739\u20135742","journal-title":"Endocrinology"},{"issue":"1","key":"186_CR45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr2931","volume":"14","author":"W Miller","year":"2012","unstructured":"Miller W, Larionov A (2012) Understanding the mechanisms of aromatase inhibitor resistance. Breast Cancer Res 14(1):201","journal-title":"Breast Cancer Res"},{"issue":"2","key":"186_CR46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1096\/fj.07-8506com","volume":"22","author":"B Hinz","year":"2008","unstructured":"Hinz B, Cheremina O, Brune K (2008) Acetaminophen (paracetamol) is a selective cyclooxygenase-2 inhibitor in man. FASEB J 22(2):383\u2013390","journal-title":"FASEB J"},{"issue":"1\u20132","key":"186_CR47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0165-5728(02)00438-1","volume":"135","author":"S Gerlo","year":"2003","unstructured":"Gerlo S, Vanden Berghe W, Verdood P, Hooghe-Peters EL, Kooijman R (2003) Regulation of prolactin expression in leukemic cell lines and peripheral blood mononuclear cells. J Neuroimmunol 135(1\u20132):107\u2013116","journal-title":"J Neuroimmunol"},{"issue":"4","key":"186_CR48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/bcr1678","volume":"9","author":"LR Howe","year":"2007","unstructured":"Howe LR (2007) Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer. Breast Cancer Res 9(4):210","journal-title":"Breast Cancer Res"},{"issue":"10","key":"186_CR49","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.4049\/jimmunol.173.10.5952","volume":"173","author":"S Gerlo","year":"2004","unstructured":"Gerlo S, Verdood P, Gellersen B, Hooghe-Peters EL, Kooijman R (2004) Mechanism of prostaglandin (PG)E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5\u2032-monophosphate-mediated signaling pathways. J Immunol 173(10):5952\u20135962","journal-title":"J Immunol"},{"issue":"2","key":"186_CR50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/endo-114-2-359","volume":"114","author":"A Ottlecz","year":"1984","unstructured":"Ottlecz A, Samson WK, McCann SM (1984) A possible role of prostacyclin to stimulate prolactin and growth hormone release by hypothalamic and pituitary actions, respectively. Endocrinology 114(2):359\u2013363","journal-title":"Endocrinology"},{"issue":"3","key":"186_CR51","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0090-6980(81)90104-0","volume":"22","author":"KC Wright","year":"1981","unstructured":"Wright KC, Hedge GA (1981) The effects of prostacyclin (PGI2) on prolactin secretion in vitro. Prostaglandins 22(3):433\u2013441","journal-title":"Prostaglandins"},{"issue":"1","key":"186_CR52","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/00045391-200501000-00008","volume":"12","author":"GG Graham","year":"2005","unstructured":"Graham GG, Scott KF (2005) Mechanism of action of paracetamol. Am J Ther 12(1):46\u201355","journal-title":"Am J Ther"},{"issue":"14","key":"186_CR53","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/archinte.164.14.1519","volume":"164","author":"GC Curhan","year":"2004","unstructured":"Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ (2004) Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 164(14):1519\u20131524","journal-title":"Arch Intern Med"},{"issue":"6","key":"186_CR54","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1200\/JCO.2009.25.0423","volume":"28","author":"CI Li","year":"2010","unstructured":"Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, Michael Y, O\u2019Sullivan MJ, Stefanick ML, Prentice R (2010) Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol 28(6):1005\u20131010","journal-title":"J Clin Oncol"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0186-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-013-0186-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-013-0186-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T13:06:25Z","timestamp":1559221585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-013-0186-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,21]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["186"],"URL":"https:\/\/doi.org\/10.1007\/s10552-013-0186-0","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,21]]}}}